Percentage of subjects who experience a re-occurrence of the skin tag at the removal site.
| Group | Value | 95% CI |
|---|---|---|
| Skin Tag Removal Initial Visit Plus Follow-up | 0 |
Last reviewed · How we verify
Study to Evaluate the Efficacy of Removing Skin Tags With Digiclamp
NA trial testing Digiclamp (Skin tag removal initial plus follow-up) in Achrochordon in 20 participants. Completed in 15 June 2019.
| Lead sponsor | University of Florida |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 20 |
| Start date | 1 December 2017 |
| Primary completion | 15 June 2019 |
| Estimated completion | 15 June 2019 |
| Sites | 1 location across United States |
University of Florida
18 and older, any sex, with Achrochordon. Patients with the condition only — healthy volunteers not accepted.
Per-arm endpoint measurements with 95% confidence intervals where reported. Source: trial results section.
Percentage of subjects who experience a re-occurrence of the skin tag at the removal site.
| Group | Value | 95% CI |
|---|---|---|
| Skin Tag Removal Initial Visit Plus Follow-up | 0 |
Percentage of subjects who develop a scar at the removal site
| Group | Value | 95% CI |
|---|---|---|
| Skin Tag Removal Initial Visit Plus Follow-up | 1 |
Percentage of subjects who develop scar tissue or keloid at the site of removal
| Group | Value | 95% CI |
|---|---|---|
| Skin Tag Removal Initial Visit Plus Follow-up | 0 |
Percentage of subjects who develop discoloration at the site of removal
| Group | Value | 95% CI |
|---|---|---|
| Skin Tag Removal Initial Visit Plus Follow-up | 3 |
Percentage of subjects who develop pain/numbness at the site of removal
| Group | Value | 95% CI |
|---|---|---|
| Skin Tag Removal Initial Visit Plus Follow-up | 0 |
All study participants were asked three questions in a post procedure satisfaction survey. 1\. How satisfied are you with the amount of pain you experienced while having your skin tag removed? Study participants responded whether they were "very satisfied", "somewhat satisfied", "neither satisfied nor dissatisfied", "somewhat dissatisfied", "very dissatisfied". Subjects were counted in each category and reported.
| Group | Value | 95% CI |
|---|---|---|
| Skin Tag Removal Initial Visit Plus Follow-up | 20 | |
| Skin Tag Removal Initial Visit Plus Follow-up | 0 | |
| Skin Tag Removal Initial Visit Plus Follow-up | 0 | |
| Skin Tag Removal Initial Visit Plus Follow-up | 0 |
All study participants were given a satisfaction survey 2 months post procedure. Subjects had to choose if they were "very satisfied:, "somewhat satisfied", "neither satisfied nor dissatisfied", "somewhat dissatisfied", "very dissatisfied" with how the area looks where the skin tag used to be. Subjects in each category were counted and reported.
| Group | Value | 95% CI |
|---|---|---|
| Skin Tag Removal Initial Visit Plus Follow-up | 19 | |
| Skin Tag Removal Initial Visit Plus Follow-up | 1 | |
| Skin Tag Removal Initial Visit Plus Follow-up | 0 | |
| Skin Tag Removal Initial Visit Plus Follow-up | 0 |
All study participants were asked a satisfaction survey post procedure and whether they would recommend the procedure to friends and family. Categories for response were: "very likely", "somewhat likely", "neither likely nor unlikely", "somewhat unlikely", "very unlikely". Subjects in each category were counted and reported.
| Group | Value | 95% CI |
|---|---|---|
| Skin Tag Removal Initial Visit Plus Follow-up | 20 | |
| Skin Tag Removal Initial Visit Plus Follow-up | 0 | |
| Skin Tag Removal Initial Visit Plus Follow-up | 0 | |
| Skin Tag Removal Initial Visit Plus Follow-up | 0 |
The objective of this study is to assess the efficacy of using the Digiclamp device to remove achrocordons (skin tags). The hypothesis is that utilizing the device will result in low rates of re-occurrence, scars, scar tissue and discoloration at the site of removal.
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
Currently open trials in the same condition.
Trials by the same sponsor.
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03259295.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing